In this study, we demonstrated that VIM staining can be jointly performed with CD8+ TIL quantification so that SCLC-M tumors with Vim+ and a low CD8+ TIL score can be identified in clinical cohorts. Here, CD8A is linked to small cell lung carcinoma.